Results 151 to 160 of about 47,663 (257)

Vividness of Visual Imagery and Personality Impact Motor-Imagery Brain Computer Interfaces. [PDF]

Front Hum Neurosci, 2021
Leeuwis N, Paas A, Alimardani M.
europepmc   +1 more source

Choroid Plexus Enlargement and USPIO‐Based Inflammatory Feature in Cerebral Small Vessel Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective The choroid plexus (CP) is a key component of the blood–cerebrospinal fluid barrier (BCSFB), but its mechanism of action in cerebral small vessel disease (CSVD) remains unclear. This study investigated CP volume (CPV) alterations and their association with conventional imaging markers in CSVD and explored the underlying role of ...
Yongqiang Qu, Xiaoning Ren, Cuihua Fan, Chun Li, Lijie Zhang, Zaiqiang Zhang, Shaowu Li, Zhongmeng Lai, Bin Cai, Ying Fu, Yi Lin, Zhibao Zhu   +11 more
wiley   +1 more source

Neurodiversity in mental simulation: conceptual but not visual imagery priming modulates perception across the imagery vividness spectrum. [PDF]

Sci Rep
Welker Á, Pető-Plaszkó O, Verebélyi L, Gombos F, Winkler I, Kovács I.   +5 more
europepmc   +1 more source

Interactions between the neural correlates of dispositional internally directed thought and visual imagery. [PDF]

Philos Trans R Soc Lond B Biol Sci, 2021
Karapanagiotidis T, Jefferies E, Smallwood J.   +2 more
europepmc   +1 more source

Advancing Age Modulates Associations Between Cognitive Impairment and Brain Volumes in Early MS

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Introduction Cognitive impairment is common in multiple sclerosis (MS), but manifestations following the first demyelinating event are relatively unexplored. We investigated cross‐sectional associations between magnetic resonance imaging (MRI)–derived brain volumes and the presence of cognitive impairment outcomes five years after the first ...
Piriyankan Ananthavarathan, Marco Pitteri, Michael Foster, Sara Collorone, Sara Salama, Elisa Colato, Ferran Prados, Baris Kanber, Marios Yiannakas, Claudia A. M. Gandini Wheeler‐Kingshott, Indran Davagnanam, Frederik Barkhof, Declan Chard, Olga Ciccarelli, Ahmed Toosy   +14 more
wiley   +1 more source

Understanding Further the Phenotypic Spectrum of Central Nervous System Inflammatory Demyelinating Disorders Using Unsupervised Clustering

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Central nervous system (CNS) inflammatory demyelinating syndromes, including multiple sclerosis (MS), aquaporin‐4 antibody–positive neuromyelitis optica spectrum disorder (AQP4 + NMOSD), and myelin oligodendrocyte glycoprotein (MOG) antibody–associated disease (MOGAD), occasionally overlap.
Bade Gulec, Elif Everest, Melih Tutuncu, Ugur Bilge, Sabahattin Saip, Ugur Uygunoglu, Aksel Siva   +6 more
wiley   +1 more source

An international estimate of the prevalence of differing visual imagery abilities. [PDF]

Front Psychol
Wright DJ, Scott MW, Kraeutner SN, Barhoun P, Bertollo M, Campbell MJ, Waltzing BM, Dahm SF, Esselaar M, Frank C, Hardwick RM, Fuelscher I, Marshall B, Hodges NJ, Hyde C, Holmes PS.   +15 more
europepmc   +1 more source

Distinct Representational Structure and Localization for Visual Encoding and Recall during Visual Imagery. [PDF]

Cereb Cortex, 2021
Bainbridge WA, Hall EH, Baker CI.
europepmc   +1 more source

Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: A Comparison With Rituximab

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan, Lei Zhou, Jingzi ZhangBao, Hongmei Tan, Zhouzhou Wang, Chao Quan   +5 more
wiley   +1 more source

Neural mechanisms of psychedelic visual imagery. [PDF]

Mol Psychiatry
Stoliker D, Preller KH, Novelli L, Anticevic A, Egan GF, Vollenweider FX, Razi A.   +6 more
europepmc   +1 more source